30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

3Q13 Revenue: aap Implantate

€8.8MM (~US $11.7MM), +2%

  • Trauma ~$3MM, +50%
  • LOQTEQ ~$1.5MM, +83%
  • Trauma growth driven by SMIT (South Korea, Mexico, Indonesia, Turkey) and BRIC (Brazil, Russia, India, China)
  • Signed new LOQTEQ distribution agreement with Saudi Arabia distributor, to commence 4Q13
  • First LOQTEQ delivery to distributor in Bulgaria
  • Received CE Mark Approval for 4 new plating systems